Pyruvate Kinase Deficiency:
Reflections on the Patient Experience
to Support Treatment and Care

Key learnings from the lived experiences
of people with pyruvate kinase (PK)
deficiency worldwide to help shape
patient-centered treatment and care.

This study and white paper were conducted in collaboration between Agios and a multidisciplinary group of patients, advocates and clinicians founded and funded by Agios. Medical writing support was provided by FleishmanHillard, paid for by Agios Pharmaceuticals, Inc.

Click to download